Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-10-038860
Filing Date
2010-09-29
Accepted
2010-09-29 12:07:52
Documents
1
Period of Report
2010-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3943
  Complete submission text file 0001140361-10-038860.txt   5756
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O REPLIGEN CORP 41 SEYON ST. BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address
RUSCHE JAMES R (Reporting) CIK: 0001241031 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 101095572